Synthesis of 8(R),9(R)-9-deoxo-4''-deoxy-6,9-epoxyerythromycin: Potent motilides

European Journal of Medicinal Chemistry

Volumn 34, Issue 3, 1999, Pages 261-264

  Faghih, Ramin ^a   Burnell Curty, Cynthia ^a   Lartey, Paul A ^a   Petersen, Albert ^a   Klein, Larry L ^a   Bennani, Youssef L ^a   Nellans, Hugh N ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Epoxyerythromycin; Erythromycin A; Gastrointestinal prokinetic activity; Motilide; Motilin

Indexed keywords

ALEMCINAL; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; PROKINETIC AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG HALF LIFE; DRUG POTENCY; DRUG SCREENING; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; MALE; NONHUMAN;

EID: 0032757367     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(99)80059-2     Document Type: Article

References (19)

1. Tonini M. Pharmacol. Res. 33:1996;217.
2. Lartey P.A., Nellans H.N., Tanaka S.K. Adv. Pharmacol. 28:1994;307.
3. Itoh Z. Peptides. 18:1997;593.
4. Verlinden M., Craft C., Olson C. Gastroenterology. 112:1997;A846.
5. Verhagen M.A.M.T., Samson M., Kroodsma J.M., Edmonds A., Smout A.J.P.M. Gastroenterology. 110:1996;A776.
6. Faghih R., Lartey P.A., Pagano T., Nellans H., Petersen A.C., Marsh K., Plattner J.J. 13th International Symposium on Medicinal Chemistry, Paris, France Abstracts of Papers. Abstract P145:1994.
7. Lartey P.A., Nellans H.N., Faghih R., Petersen A., Edwards C.M., Freiberg L., Quigley S., Marsh K., Klein L.L., Plattner J.J. J. Med. Chem. 38:1995;1793.
8. Itoh Z., Omura S. Dig. Dis. Sci. 32:1987;915.
9. Faghih R., Lartey P.A., Nellans H.N., Seif L., Burnell-Curty C., Klein L.L., Thomas P., Petersen A., Borre A., Pagano T., Kim K.H., Heindel M., Bennani Y.L., Plattner J.J. J. Med. Chem. 41:1998;3402.
10. Klein L.L., Freiberg L., Kurath P., Henry R.F. J. Org. Chem. 58:1993;3209.
11. 2O) C, H, N.
12. Freiberg L.A., U. S. Patent 3 725 385, (1973).
13. 50 (-log concentration yielding half-maximal contraction) was calculated as a comparative parameter for evaluating potency.
14. Tsuzuki K., Sunazuka T., Marui S., Toyoda H., Omura S., Inatomi N., Itoh Z. Chem. Pharm. Bull. 37:1989;2687.
15. Sunazuka T., Tsuzuki K., Marui S., Toyoda H., Omura S., Inatomi N., Itoh Z. Chem. Pharm. Bull. 37:1989;2701.
16. 4 (pH 6.9)/MeCN/MeOH, 42:5:48, YMC ODS-A column). The fraction of compound remaining was plotted with reference to the initial peak area, and acid stability rate constants and disappearance half-lives were calculated.
17. Takanashi H., Yogo K., Ozaki K., Ikuta M., Koga H., Nabata H. Gastroenterology. 106:1994;A575.
18. Koga H., Tsuzuki K., Sato T., Yogo K., Takanashi H. Bioorg. Med. Chem. Lett. 5:1995;835.
19. Faghih R., Nellans H.N., Lartey P.A., Petersen A., Marsh K., Bennani Y.L., Plattner J.J. Bioorg. Med. Chem. Lett. 8:1998;805.